CDXC today
Trend
—
Key levels
—
Latest news & SEC filings
SEC FilingNiagen Bioscience, Inc. filed a report on a major company event (Form 8-K)
All CDXC news →Nasdaq · Healthcare
Niagen Bioscience, Inc. (CDXC)
What Is the Price Target for CDXC?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is CDXC a Buy or Sell Right Now?
Thesis
- •Revenue growing 29.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CDXC.
Start Free Trial →Is CDXC Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
P/E Forward
Fair Value
$4.99
17
Moat Score
NONE
5/9
Piotroski Score
11.8
Altman Z-Score
What Is Smart Money Doing with CDXC?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CDXC Growth Story
Revenue YoY
29.9%
3yr Revenue CAGR
21.6%
EPS Growth YoY
81.82%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Niagen Bioscience, Inc. (CDXC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CDXC — frequently asked questions
Why is CDXC stock moving today?
Latest CDXC news — Nov 4, 2026: Niagen Bioscience, Inc. filed a report on a major company event (Form 8-K)
Did CDXC beat earnings?
CDXC last reported on Mar 4, 2026: EPS $0.05.
What is CDXC's P/E ratio?
CDXC trades at a P/E of 47.2.
Does CDXC pay a dividend?
CDXC does not currently pay a dividend.
What are insiders doing with CDXC?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on CDXC?
Nov 4, 2026: Niagen Bioscience, Inc. filed a report on a major company event (Form 8-K)